CCI
IPXL

Columbus Circle Investors’s Impax Laboratories, Inc. IPXL Stock Holding History

Columbus Circle Investors’s Portfolio IPXL Stock Details IPXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-42,047
Closed -$532K – 325
2017
Q1 		$532K Buy
+42,047
New +$508K 0.01% 264

Other funds holding IPXL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Columbus Circle Investors's IPXL Position: Q2 2017 in Review

Columbus Circle Investors sold out of Impax Laboratories, Inc. (IPXL) in Q2 2017, closing a stake of 42,047 shares — an estimated $532K sold.

Columbus Circle Investors first reported a position in IPXL in Q1 2017 and held it in 1 quarter. The position peaked at $532K in Q1 2017. 172 funds tracked by Wall St. Rank hold IPXL as of Q2 2017.

  • Columbus Circle Investors reported no remaining Impax Laboratories, Inc. position as of Q2 2017 after selling out during the quarter.
  • Columbus Circle Investors sold 42,047 Impax Laboratories, Inc. shares in Q2 2017, an estimated $532K.
  • Columbus Circle Investors first reported a position in Impax Laboratories, Inc. in Q1 2017 and held it in 1 quarter.
  • Columbus Circle Investors's Impax Laboratories, Inc. position peaked at $532K in Q1 2017.
  • 172 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2017.

Based on Columbus Circle Investors's 13F filing for Q2 2017, filed 4 Aug 2017.